D314DRM Protecta XT DR
Implantable Cardioverter Defibrillator (ICD)
D314DRM Protecta XT DR
Information

Device Survival Probability

D3xxDRx_SURV
Loading...










    1 yr 2 yr 3 yr 4 yr 5 yr 6 yr 7 yr at 87.0 mo    
% Excluding Normal Battery Depletion 100.0 100.0 99.9 99.9 99.9 99.9 99.8 99.8    
% Including Normal Battery Depletion 99.8 99.7 99.5 99.1 97.4 92.1 78.0 62.8    
#   55802 52433 49202 45642 40684 27244 4802 770    
  • Including Normal Battery Depletion – This curve includes devices that have reached at least 80% of expected longevity. This curve is most representative of clinical performance and how long the device will last.
  • Excluding Normal Battery Depletion – This is the malfunction free survival curve.
Information

Advisories For This Model

  • There are no advisories for this model.

Performance Notes For This Model

    • There are no performance notes for this model.
Information

Product Characteristics

Generator Type ICD
NBD Code DDE-DDDR
Max. Delivered Energy 35 J
More
Connector Style DF4 DR Style
Serial Number Prefix PSJ
Mass 73 g
Volume 41 cc
Waveform Biphasic
X-Ray ID PSI
Hide this content
DF4 DR Style
Information

Estimated Longevity

Charging Frequency 100% Pacing 50% Pacing 15% Pacing 100% Sensing
Monthly 3.6 4.1 4.5 4.7
Quarterly 5.1 6.0 7.0 7.5
Semi-annual 5.7 7.0 8.3 9.0
Footnote

Longevity estimates based on the following device usage. Pacing Mode DDD; Atrial Lower Pacing Rate 60ppm; Ventricular Lower Pacing Rate 60ppm; Atrial Pulse Width 0.4ms; Ventricular Pulse Width 0.4ms; Atrial Pulse Amplitude 3V; Ventricular Pulse Amplitude 3V; Atrial Impedance 510ohms; Ventricle Impedance 510ohms; Atrial Sensing Rate 70bpm; Ventricle Sensing Rate 70bpm; EGM prestorage OFF; Optivol ON; Atrial Fib percentage of time 0%; Charging frequency assumes maximum energy charge and includes therapy shocks and capacitor formation. Hide this content

Information

Distribution Data

US Market Release2011-11-09
CE Approval Date
Registered USA Implants13923
Estimated Active USA Implants9676
Normal Battery Depletions391
US Market Release2011-11-09
CE Approval Date
Estimated WW Distribution14821
Normal Battery Depletions392
Information

Malfunctions (USA)

Therapy Function Not Compromised 14
Battery 1
Electrical Component 12
Other 1
Therapy Function Compromised 2
Battery 2
Information

Malfunctions (WW)

Therapy Function Not Compromised 15
Battery 1
Electrical Component 13
Other 1
Therapy Function Compromised 2
Battery 2
Information

EOS Indication

From the point that the RRT is set, the pacemaker will operate for approximately three months for typical pacemaker configurations during the normal operating life.

Information

Recommended Replacement (RRT)

Battery voltage less than or equal to 2.63V on 3 consecutive daily automatic measurments.

Information

Charge Time

D314DRx_CHRG
Loading...

Data as of April 11, 2019

www.medtronic.com/productperformance 651050